4th Quarter - Report

NOVOCURE INC. for NOVOCURE INC.

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$120,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report (this page) Jan 20, 2023 $120,000 Replaced
4th Quarter - Amendment Feb 18, 2023 $120,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

General Medicare / Medicaid Issues. H.R.4043 - Ensuring Patient Access to Critical Breakthrough Products Act of 2021.

LobbyistCovered position, as disclosed
EMILY HAAS New Senior Policy Advisor, Congressman Conor Lamb; Legislative Aide for Congresswoman Allyson Schwartz
KATHERINE MEYER Senior Policy Advisor, Office of House Republican Leader Kevin McCarthy; Deputy Health Policy Director, Senate Finance Committee; Health Policy Advisor, Senator Orrin Hatch; Sr. LA, Congressman Erik Paulsen; LA, Congressman Jeff Fortenberry

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4043 (117th)

Veterans VET

Veteran Affairs Issues.

LobbyistCovered position, as disclosed
EMILY HAAS —
KATHERINE MEYER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; White House Office

Transportation TRA

TSA Issues.

LobbyistCovered position, as disclosed
EMILY HAAS —
KATHERINE MEYER —

Contacted: Transportation Security Administration (TSA); Homeland Security, Dept of (DHS); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.